Taiwan Advance Bio-Pharmaceutical Inc (TABP, 台灣尖端先進生技醫藥) and General Biologicals Corp (GBC, 普生股份) yesterday separately said that they have a good chance of being chosen to produce a rapid screening reagent for COVID-19.
The two were among 10 companies that attended a conference with Academia Sinica last week.
Yesterday’s announcement came after the institute on Sunday announced that it has synthesized a monoclonal antibody that can quickly identify the coronavirus that causes COVID-19.
“Academia Sinica said in the meeting that it has certain criteria to select qualified manufacturers for the test kits. It seems that we have a chance and we will keep in close contact with the institute,” TABP deputy director Chang Chih-feng (張志鋒) told the Taipei Times by telephone.
TABP, which focuses on test kits for antibiotics and pesticide residue in food, produces about 12,000 kits per week at its factory in New Taipei City, Chang said.
“We could allocate production capacity to mass produce the reagents by running the machines in extra shifts and recruit more operators,” he said.
As TABP has not produced reagents for human use, it might need to gain regulatory approval before starting production, he added.
GBC president Frank Lin (林孟德) said by phone that the supplier of diagnostic test kits for hepatitis B, C and D has a better chance of winning the contract, as it has been producing reagents for human use for more than 30 years.
“The production should not be difficult, as the institute is expected to provide the monoclonal antibody, which we can rapidly regenerate in mice,” Lin said.
“Synthesizing the monoclonal antibody that can identify COVID-19 is the more challenging part in the development of reagents, but we do not need to worry about it,” he said.
Both companies said they would continue negotiating with the institute over whether it would contract them to produce the kits.
The other companies that attended the meeting included AsiaGen Corp (亞洲基因), Firstep Bioresearch Inc (聯華生技), Panion & BF Biotech Inc (寶齡富錦), Formosa Biomedical Technology Corp (台塑生醫), Lihpao Life Science Corp (麗寶生醫), iXensor Co Ltd (安盛生科) and Eternal Materials Co Ltd (長興材料), said the Ministry of Economic Affairs, which helped organize the meeting.
“Many companies were interested in collaborating with Academia Sinica, as the business might be lucrative. Rapid screening reagents are not as accurate, but could be widely applied,” a ministry official said.
Medigen Vaccine Biologics Corp (高端疫苗), which last month sent an application to the health regulator for its new COVID-19 reagent that utilizes a polymerase chain reaction technique, said it would continue to focus on its own product, spokesman Leo Lee (李思賢) said.
Hon Hai Precision Industry Co (鴻海精密) yesterday said that its research institute has launched its first advanced artificial intelligence (AI) large language model (LLM) using traditional Chinese, with technology assistance from Nvidia Corp. Hon Hai, also known as Foxconn Technology Group (富士康科技集團), said the LLM, FoxBrain, is expected to improve its data analysis capabilities for smart manufacturing, and electric vehicle and smart city development. An LLM is a type of AI trained on vast amounts of text data and uses deep learning techniques, particularly neural networks, to process and generate language. They are essential for building and improving AI-powered servers. Nvidia provided assistance
GREAT SUCCESS: Republican Senator Todd Young expressed surprise at Trump’s comments and said he expects the administration to keep the program running US lawmakers who helped secure billions of dollars in subsidies for domestic semiconductor manufacturing rejected US President Donald Trump’s call to revoke the 2022 CHIPS and Science Act, signaling that any repeal effort in the US Congress would fall short. US Senate Minority Leader Chuck Schumer, who negotiated the law, on Wednesday said that Trump’s demand would fail, while a top Republican proponent, US Senator Todd Young, expressed surprise at the president’s comments and said he expects the administration to keep the program running. The CHIPS Act is “essential for America leading the world in tech, leading the world in AI [artificial
DOMESTIC SUPPLY: The probe comes as Donald Trump has called for the repeal of the US$52.7 billion CHIPS and Science Act, which the US Congress passed in 2022 The Office of the US Trade Representative is to hold a hearing tomorrow into older Chinese-made “legacy” semiconductors that could heap more US tariffs on chips from China that power everyday goods from cars to washing machines to telecoms equipment. The probe, which began during former US president Joe Biden’s tenure in December last year, aims to protect US and other semiconductor producers from China’s massive state-driven buildup of domestic chip supply. A 50 percent US tariff on Chinese semiconductors began on Jan. 1. Legacy chips use older manufacturing processes introduced more than a decade ago and are often far simpler than
Gasoline and diesel prices this week are to decrease NT$0.5 and NT$1 per liter respectively as international crude prices continued to fall last week, CPC Corp, Taiwan (CPC, 台灣中油) and Formosa Petrochemical Corp (台塑石化) said yesterday. Effective today, gasoline prices at CPC and Formosa stations are to decrease to NT$29.2, NT$30.7 and NT$32.7 per liter for 92, 95 and 98-octane unleaded gasoline respectively, while premium diesel is to cost NT$27.9 per liter at CPC stations and NT$27.7 at Formosa pumps, the companies said in separate statements. Global crude oil prices dropped last week after the eight OPEC+ members said they would
RSS